Blinded Independent Validation Study Highlights Effectiveness of Tissue Systems Pathology Test in Predicting Risk of Progression to Esophageal Cancer in Patients with Barrett's Esophagus
May 21, 2019 17:15 ET
|
Cernostics
Data Presented at DDW 2019 Demonstrate Test Potential to Identify Patients Who May Benefit from Increased Surveillance and Early Therapeutic Intervention PITTSBURGH, PA, May 21, 2019 (GLOBE...
Interpace Diagnostics Enters into Agreement with University of Maryland Medical System
January 14, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Agreement Provides Access to Company’s Available Molecular Diagnostic Tests PARSIPPANY, NJ, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) has entered in to an...
Interpace Diagnostics CEO Provides Corporate Update
October 10, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) is pleased to provide a corporate update to shareholders on current business activities from its Chief...
American Cancer Society to Honor ENT and Allergy Associates
April 30, 2015 10:55 ET
|
Ent and Allergy
WHITE PLAINS, N.Y., April 30, 2015 (GLOBE NEWSWIRE) -- On Friday, June 19, 2015, the American Cancer Society will honor ENT & Allergy Associates, LLP at the annual Diamond Gala. This year, the event...